Systems validation: application to statistical programs
<p>Abstract</p> <p>Background</p> <p>In 2003, the United States Food and Drug Administration (FDA) released a guidance document on the scope of "Part 11" enforcement. In this guidance document, the FDA indicates an expectation of a risk-based approach to deter...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-01-01
|
Series: | BMC Medical Research Methodology |
Online Access: | http://www.biomedcentral.com/1471-2288/5/3 |
id |
doaj-c183d783ab664fe29432fbec886bc286 |
---|---|
record_format |
Article |
spelling |
doaj-c183d783ab664fe29432fbec886bc2862020-11-24T21:01:37ZengBMCBMC Medical Research Methodology1471-22882005-01-0151310.1186/1471-2288-5-3Systems validation: application to statistical programsCarter Rickey E<p>Abstract</p> <p>Background</p> <p>In 2003, the United States Food and Drug Administration (FDA) released a guidance document on the scope of "Part 11" enforcement. In this guidance document, the FDA indicates an expectation of a risk-based approach to determining which systems should undergo validation. Since statistical programs manage and manipulate raw data, their implementation should be critically reviewed to determine whether or not they should undergo validation. However, the concepts of validation are not often discussed in biostatistics curriculum.</p> <p>Discussion</p> <p>This paper summarizes a "Plan, Do, Say" approach to validation that can be incorporated into statistical training so that biostatisticians can understand and implement validation principles in their research.</p> <p>Summary</p> <p>Validation is a process that requires dedicated attention. The process of validation can be easily understood in the context of the scientific method.</p> http://www.biomedcentral.com/1471-2288/5/3 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Carter Rickey E |
spellingShingle |
Carter Rickey E Systems validation: application to statistical programs BMC Medical Research Methodology |
author_facet |
Carter Rickey E |
author_sort |
Carter Rickey E |
title |
Systems validation: application to statistical programs |
title_short |
Systems validation: application to statistical programs |
title_full |
Systems validation: application to statistical programs |
title_fullStr |
Systems validation: application to statistical programs |
title_full_unstemmed |
Systems validation: application to statistical programs |
title_sort |
systems validation: application to statistical programs |
publisher |
BMC |
series |
BMC Medical Research Methodology |
issn |
1471-2288 |
publishDate |
2005-01-01 |
description |
<p>Abstract</p> <p>Background</p> <p>In 2003, the United States Food and Drug Administration (FDA) released a guidance document on the scope of "Part 11" enforcement. In this guidance document, the FDA indicates an expectation of a risk-based approach to determining which systems should undergo validation. Since statistical programs manage and manipulate raw data, their implementation should be critically reviewed to determine whether or not they should undergo validation. However, the concepts of validation are not often discussed in biostatistics curriculum.</p> <p>Discussion</p> <p>This paper summarizes a "Plan, Do, Say" approach to validation that can be incorporated into statistical training so that biostatisticians can understand and implement validation principles in their research.</p> <p>Summary</p> <p>Validation is a process that requires dedicated attention. The process of validation can be easily understood in the context of the scientific method.</p> |
url |
http://www.biomedcentral.com/1471-2288/5/3 |
work_keys_str_mv |
AT carterrickeye systemsvalidationapplicationtostatisticalprograms |
_version_ |
1716777467714207744 |